Skip to main content
Clinical Trials/NL-OMON51014
NL-OMON51014
Withdrawn
N/A

Study of a novel implantable device to generate an autologous vascular graft for hemodialysis access - VACIS Rod

VACIS B.V.0 sites20 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
AVF
Sponsor
VACIS B.V.
Enrollment
20
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
VACIS B.V.

Eligibility Criteria

Inclusion Criteria

  • For this study, we aim to include a total of 20 hemodialysis patients. Patients
  • with a need for a arteriovenous access in whom only an AV graft can be
  • considered or with a history of failed previous vascular access are considered
  • to participate in this study. Patients are at least 18 and not older than 80
  • years old. To be eligible to participate in this study, a subject must meet the
  • following inclusion criteria:
  • The patient:
  • 1\) is in need of hemodialysis according to the treating nephrologist
  • 2\) has a suitable location for an AV graft, preferably in the upper arm or
  • 3\) is considered eligible for arteriovenous access surgery

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • 1\) Any concurrent illness, disability or clinically significant abnormality
  • that may as judged by the investigator, affect the interpretation of clinical
  • efficacy or safety data or prevent the subject from safely completing the
  • assessments required by the Clinical Investigation Plan.
  • 2\) Current participation in another interventional clinical trial.
  • 3\) Patient with insufficient arterial blood flow (judged by an experienced
  • 4\) Patients with insufficient venous outflow and/or with obstructions (judged
  • experienced clinician)

Outcomes

Primary Outcomes

Not specified

Similar Trials